SCHEMBL7608007

SCHEMBL7608007

Cc1cn(Nc2ccncc2)c2ccc(OCc3ccccc3)cc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.58
F2 P00734 2/20 0.50
KCNH2 Q12809 1/20 0.48
GRIN2B Q13224 1/20 0.48
MEN1 O00255 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
KMT2A Q03164 2/20 0.44
DYRK1A Q13627 1/20 0.42
ACHE P22303 2/20 0.42
BCHE P06276 1/20 0.42
PKM P14618 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAOB P27338 2/20 0.41
AS3MT Q9HBK9 1/20 0.41
CYP19A1 P11511 1/20 0.40
GABRA1 P14867 1/20 0.39
GABRB2 P47870 1/20 0.39
MAOA P21397 1/20 0.39
GRK2 P25098 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8714827 0.95 SLC6A2 (0.53) SLC6A2F2KCNH2GRIN2BMEN1
SCHEMBL8539866 0.83 BCHE (0.63) SLC6A2F2KCNH2GRIN2BMEN1
SCHEMBL8539616 0.78 SLC6A2 (0.56) SLC6A2F2KCNH2GRIN2BMEN1
SCHEMBL7620289 0.77 BCHE (0.45) F2KCNH2GRIN2BMEN1NPC1
SCHEMBL7620284 0.76 BCHE (0.43) F2KCNH2GRIN2BMEN1NPC1
SCHEMBL8544882 0.76 NPC1 (0.53) MEN1NPC1RAB9AKMT2ADYRK1A
SCHEMBL7611582 0.75 SLC6A2 (1.00) SLC6A2ACHEBCHE
SCHEMBL8836224 0.75 SPHK2 (0.48) MEN1NPC1RAB9AKMT2APKM
SCHEMBL8836219 0.75 LTA4H (0.50) MEN1NPC1RAB9AKMT2APKM
SCHEMBL7614900 0.74 SLC6A2 (0.64) SLC6A2MEN1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0840609-B1 USE OF UNSUBSTITUTED AND SUBSTITUTED N-(PYRROL-1-YL)PYRIDINAMINES AS ANTICONVULSANT AGENTS AVENTIS PHARMA INC (US) 2002-06-05 EP disclosed
EP-0468401-B1 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process for their preparation and their use as medicaments HOECHST MARION ROUSSEL INC (US) 1998-09-16 EP disclosed
US-5776955-A Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents HOECHST MARION ROUSSEL, INC. 1998-07-07 US disclosed
US-5102891-A Useful for treating various memory dysfunctions such as alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-04-07 US disclosed
EP-0468401-A2 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-01-29 EP disclosed